Summary:
- The article discusses concerns about the presence of residual DNA in the BioNTech mRNA-based COVID-19 vaccines, including the potential inclusion of an SV40 promoter-enhancer sequence.
- The article cites a study that found significant amounts of residual DNA in the BioNTech vaccine, which the authors suggest could potentially lead to unintended gene expression and safety issues.
- The article highlights the need for further research and transparency from vaccine manufacturers to address these concerns and ensure the safety and efficacy of mRNA-based COVID-19 vaccines.